Prentiss Smith & Co’s Chemours CC Stock Holding History

Prentiss Smith & Co’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-150	Closed	-$6K	–	88
2018 Q3	$6K	Hold	150	–	–	﹤0.01%	226
2018 Q2	$7K	Buy	+150	New	+$7.46K	﹤0.01%	222
2016 Q2	–	Sell	-615	Closed	-$4K	–	278
2016 Q1	$4K	Hold	615	–	–	﹤0.01%	269
2015 Q4	$3K	Hold	615	–	–	﹤0.01%	295
2015 Q3	$4K	Buy	+615	New	+$6.44K	﹤0.01%	268

Other funds holding CC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Prentiss Smith & Co's CC Position: Q4 2018 in Review

Prentiss Smith & Co sold out of Chemours (CC) in Q4 2018, closing a stake of 150 shares — an estimated $6K sold.

Prentiss Smith & Co first reported a position in CC in Q3 2015 and held it in 5 quarters. The position peaked at $7K in Q2 2018. 507 funds tracked by Wall St. Rank hold CC as of Q4 2018.

Prentiss Smith & Co reported no remaining Chemours position as of Q4 2018 after selling out during the quarter.
Prentiss Smith & Co sold 150 Chemours shares in Q4 2018, an estimated $6K.
Prentiss Smith & Co first reported a position in Chemours in Q3 2015 and held it in 5 quarters.
Prentiss Smith & Co's Chemours position peaked at $7K in Q2 2018.
507 funds tracked by Wall St. Rank held Chemours as of Q4 2018.

Based on Prentiss Smith & Co's 13F filing for Q4 2018, filed 15 Jan 2019.